This Week's Economic Indicator Calendar Latest FX Fundamentals & Geopolitical Risk Analysis 'Tokozou Model Ver8.0' Thorough ...

An externally validated two-stage blood-biomarker algorithm reduced the need for amyloid PET by resolving more uncertain p-Tau217 results while retaining imaging for residual uncertainty.

Aclarion reports 85% scan volume growth in Q3 2026, expanding the CLARITY trial and securing funding through mid-2027.

A simple selfie could hold surprising clues to your overall health and longevity, especially among people with cancer.

U.S. consumers aren't just frustrated with high prices. They're angry and confused about the increasingly high-tech ways that ...